The pull factors are no secret. India offers a deep pool of HIPAA-ready healthcare technology talent, operating costs that run 30 to 50 percent below US equivalents, and a regulatory framework mature enough to handle protected health information at scale. The bigger shift is what’s being built on top of that foundation: innovation, not just operations.

• Talent supply meets the US healthcare skills gap. 1.India graduates around 2.5 million STEM students a year and has roughly 2.7 million life sciences professionals to draw from. For US health systems struggling to staff data engineering, clinical informatics, and compliance roles, that is the largest accessible pool of healthcare technology talent in the world.
• Cost arbitrage is real, but innovation arbitrage is the new headline. Costs run 30 to 50 percent lower than equivalent US or European functions, with junior-level talent up to 85 percent cheaper. What has changed is where the savings go. AI and ML adoption inside Indian healthcare GCCs has climbed from 65 percent to 86 percent in five years (Zinnov–AMCHAM). The money is going back into R&D, not flowing out as margin.
• Regulatory maturity has caught up with the workload. 3.Indian healthcare GCCs now run inside a layered compliance stack: HIPAA, GDPR, India’s DPDP Act 2023, FDA, EMA, ISO 27001, SOC 2, and HITRUST. That is why roughly 60 percent of global regulatory affairs work and 54 percent of pharmacovigilance operations for major life sciences firms now sit in India.
• Bengaluru, Hyderabad, and Chennai are real healthcare ecosystems. 4.These are not generic IT clusters. They sit next to medical colleges, biotech parks, and clinical trial networks. Telangana is targeting 120 plus new GCCs by the end of 2026, and AstraZeneca’s Chennai Global Innovation and Technology Centre is now the company’s largest GCC anywhere in the world.
• The move from outsourcing to wholly-owned captives is structural. 5.Optum, Carelon, Cohere Health, CVS Health, Cigna, Eli Lilly, and Bristol Myers Squibb are pulling work back from third-party vendors and into their own captives to retain IP, control PHI, and align roadmaps directly with HQ. Carelon alone has shifted roughly 72 percent of its global workforce to India.

Most failed GCC builds share the same root cause: rushing setup without local depth. The companies getting this right tend to follow a similar playbook.

• Pick the right entry model. Employer of Record (EOR) lets a US enterprise hire in India in 2 to 3 days while the entity is being set up. Build-Operate-Transfer (BOT) hands the running unit to the parent after 18 to 36 months. A direct subsidiary gives full control from day one but takes longer. For most US healthcare enterprises, BOT or EOR-to-captive is the lower-risk path.
• Anchor where the ecosystem already is. Bengaluru is best for engineering, AI/ML, and product depth. Hyderabad leads on pharma and payer-side innovation. Chennai is strong for clinical operations, R&D, and medtech. Pune and Gurugram are emerging healthtech hubs. Tier-2 cities like Coimbatore have lower attrition but thinner specialist talent. Use them as satellites, not anchors.
• Build compliance in from day one. HIPAA, DPDP Act, and HITRUST need to be designed into the platform, not added later. Privacy engineering, consent management, encryption at rest, audit trails, role-based access, and a clean Business Associate Agreement chain back to HQ are non-negotiable. Audit failures almost always trace to compliance being treated as a Phase 2 problem.
• Hire for depth, not just headcount. The roles that matter in 2026 are healthcare AI/ML architects, FHIR interoperability engineers, clinical informatics leads, HIPAA-cloud security engineers, and pharmacovigilance specialists. Pair them with a clinical advisory board of US physicians who actually mentor the engineering and data teams. Domain context is what separates a healthcare GCC from a generic tech GCC.
• Treat the GCC as a product organization, not a cost center. The mature India GCCs (Optum, Carelon, AstraZeneca, Eli Lilly, Sanofi) give their sites global P&L, product roadmap ownership, and CXO-level leadership. Per the Zinnov–Nasscom 2026 report, 64 percent of GCC site leaders now carry dual mandates combining global business unit ownership with site leadership. That is the model that unlocks the full value.

India’s GCC enablement ecosystem has consolidated around a handful of execution and strategy partners who routinely help US and European enterprises stand up offshore capability centers. The five below are among the most active in 2026, selected for their healthcare-relevant capabilities, transformation-led delivery, and India-wide track record rather than any single ranking.

• ANSR. 1.One of the most established GCC builders in India, with more than 200 GCCs set up for over 100 Fortune 500 companies across Bengaluru, Hyderabad, Pune, and Chennai. ANSR’s healthcare credentials are particularly strong: in April 2026 it launched ANSR MedTech, a capability center built for a Fortune 100 MedTech firm. The company offers full-lifecycle setup covering legal, infrastructure, leadership hiring, and operational governance, and is well suited to large enterprises building flagship India sites.
• Zinnov. Less an executor, more a strategy partner. Zinnov has guided more than 210 GCC setups and publishes the most widely cited annual research on India’s GCC ecosystem (the Zinnov–Nasscom GCC Landscape report). Healthcare leaders often engage Zinnov early for location strategy, talent benchmarking, and operating model design before a build partner is brought in.
• OptiSol Business Solutions. A Chennai-headquartered digital engineering firm that has been building and scaling GCCs for global enterprises since 2008, with a national delivery footprint and clients across the US and Europe. OptiSol’s positioning sits in transformation-led GCCs where legacy modernization and innovation run side by side, anchored by its proprietary iBEAM automation framework. The team works across healthcare, BFSI, and SaaS, with depth in HIPAA-grade engineering, AI, and data workloads. A practical pick for mid-market healthcare enterprises that want hands-on execution rather than slide-deck advisory.
• HCLTech. A long-standing Indian engineering and digital services firm with a large GCC enablement practice spanning Bengaluru, Hyderabad, Chennai, Pune, and Gurugram. HCLTech runs full lifecycle BOT and BOOT engagements with proven governance for regulated sectors, including healthcare and life sciences. Strongest fit for enterprises that need scale, multi-city execution, and a steady-state operating partner alongside the build.
• Inductus GCC. 5.A pure-play GCC enabler built around its Company Owned Partner Operated (COPO) and Digital Twin models, both designed to give clients full IP ownership with zero CapEx exposure. Inductus has been featured in mainstream business press for its GCC enablement work and is a useful option for healthcare and life sciences clients that want a focused, India-only setup partner.A practical sequencing many US healthcare enterprises now follow: bring in a strategy partner like Zinnov early, then engage an execution-led firm such as OptiSol, ANSR, or HCLTech for the build, transition, and scale-up phases.